The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analyses of primary refractory (refr) vs early relapsed (rel) large B-cell lymphoma (LBCL) from the TRANSFORM study of lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) as second-line (2L) therapy.
 
Loretta J. Nastoupil
Honoraria - ADC Therapeutics; Bristol-Myers Squibb; Caribou Biosciences; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; Janssen Oncology; Morphosys; Novartis; Takeda; TG Therapeutics
Consulting or Advisory Role - Interius Biotherapeutics; SIRPant Immunotherapeutics
Research Funding - Allogene Therapeutics; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Epizyme; Genentech/Roche; Gilead Sciences; IgM Biosciences; Janssen Biotech; Novartis; Takeda
Travel, Accommodations, Expenses - Genentech/Roche
 
Manali K. Kamdar
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Genentech/Roche; Syncopation Life Sciences
Speakers' Bureau - Seagen
Research Funding - Novartis
 
Julio C. Chavez
Honoraria - Adaptive Biotechnologies; Lilly
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca; BMSi; Cellectar; Genmab; Janssen; Kite/Gilead; Novartis; TeneoBio
Speakers' Bureau - Epizyme
Research Funding - Adaptive Biotechnologies; AstraZeneca; Merck (Inst)
 
Herve Ghesquieres
Honoraria - Gilead Sciences; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Roche
Travel, Accommodations, Expenses - Abbvie
 
Monalisa Ghosh
Employment - Perthera (I)
Stock and Other Ownership Interests - Perthera (I)
Research Funding - Bristol-Myers Squibb; Miltenyi Biomedicine; Novartis
 
Houston Holmes
Leadership - Exuma Biotech
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene/Juno; Celgene; crispr therapeutics; Epizyme; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Rigel; TG Therapeutics
Speakers' Bureau - Dova Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Rigel; Seagen
Research Funding - ADC Therapeutics (Inst); Adicet Bio (Inst); Allogene Therapeutics (Inst); Artiva (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene (Inst); Caribou Biosciences (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); MorphoSys (Inst); Novartis (Inst); Precision Biosciences (Inst); Viracta Therapeutics (Inst)
 
Armando López Guillermo
Honoraria - Roche
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kern Pharma; Kite/Gilead; Pfizer; Roche; Takeda
Research Funding - Celgene/Bristol-Myers Squibb; Janssen; Roche
Travel, Accommodations, Expenses - Kite/Gilead; Roche
 
Joaquin Martinez-Lopez
Honoraria - BMSi; Janssen Oncology
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
 
Urban Novak
Consulting or Advisory Role - AstraZeneca; Celgene; Gilead Sciences; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Roche; Takeda
 
Vincent Ribrag
Honoraria - Abbvie; AZD; Gilead Sciences; Infinity Pharmaceuticals; NanoString Technologies; Novartis; roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Immune Design; Incyte; Infinity Pharmaceuticals; MSD; NanoString Technologies; PharmaMar; Roche; Roche/Genentech
Research Funding - arGEN-X BVBA; argenx (Inst); Astex Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline/Adaptimmune (Inst)
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - azd; AZD; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche
 
Claire Roddie
Honoraria - Bristol-Myers Squibb; Kite/gilead; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Kite/gilead; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Kite/gilead; Novartis
 
Edmund K. Waller
Leadership - CAMBIUM MEDICAL TECHNOLOGIES; CAMBIUM MEDICAL TECHNOLOGIES
Stock and Other Ownership Interests - CAMBIUM MEDICAL TECHNOLOGIES; CAMBIUM MEDICAL TECHNOLOGIES; Cerus; Chimerix; Chimerix
Honoraria - Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Pharmacyclics; Verastem
Consulting or Advisory Role - Cambium Medical Technologies; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Partners Healthcare; Pharmacyclics; Verastem
Research Funding - Amgen; Juno Therapeutics; Novartis; Partners Healthcare; Partners Healthcare; Verastem
Patents, Royalties, Other Intellectual Property - Receive Royalties from patent on preparing platelet lysate that has been licensed to Cambium Medical Technologies
Travel, Accommodations, Expenses - Pharmacyclics
 
Tatyana A Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genmab; Seagen
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Seagen; Takeda
 
Allison Claire Rosenthal
Consulting or Advisory Role - Curio Science
 
Craig Sauter
Consulting or Advisory Role - Bristol-Myers Squibb; CRISPR Therapeutics; Kite, a Gilead Company; Ono Pharmaceutical; Syncopation Life Sciences
Research Funding - Actinium Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Genzyme (Inst); Kite, a Gilead Company (Inst); NKARTA (Inst); Precision Biosciences (Inst)
 
Malte Von Bonin
Research Funding - Janssen
Travel, Accommodations, Expenses - Gilead Sciences; Kite, a Gilead Company; Novartis
 
Reem Karmali
Honoraria - Bio Ascend; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Calithera Biosciences; EUSA Pharma; Genentech/Roche; Gilead Sciences; Lilly; Miltenyi Biotec
Speakers' Bureau - AstraZeneca; BeiGene; MorphoSys/Incyte
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Miltenyi Biotec (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Sandrine Montheard
Employment - Celgene
Stock and Other Ownership Interests - Alcon; Celgene; Novartis
 
Alessandro Previtali
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jeremy S. Abramson
Honoraria - AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen; Regeneron
Consulting or Advisory Role - Abbvie; Alimera Sciences; AstraZeneca; BeiGene; Bluebird Bio; Bristol-Myers Squibb; C4 Therapeutics; Caribou Biosciences; Celgene; Cellectar; Century Therapeutics; EMD Serono; Epizyme; Genentech; Genmab; Incyte; Interius Biotherapeutics; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Kymera; Lilly; MorphoSys; MorphoSys; MustangBio; Novartis; Ono Pharmaceutical; Takeda
Research Funding - AI Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Seagen (Inst)